Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
British Journal of Cancer
|
October 17, 2003
A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
S Madhusudan, A Protheroe, D Propper, et al.
Nature Medicine
|
July 8, 1999
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis
R J Moore, D M Owens, G Stamp, et al.
Cell Proliferation
|
September 20, 2007
Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression
N F Li, S Broad, Y J Lu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust
F Balkwill, R C Bast, J Berek, et al.
Cancer Research
|
August 27, 1999
The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients
P Thavasu, D Propper, A McDonald, et al.
Oncogene
|
January 24, 2012
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
K M Archibald, H Kulbe, J Kwong, et al.
British Journal of Cancer
|
May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
P H Jones, K Christodoulos, N Dobbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C
D J Propper, A C McDonald, A Man, et al.
British Journal of Cancer
|
May 27, 2010
Guidelines for the welfare and use of animals in cancer research
P Workman, E O Aboagye, F Balkwill, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
British Journal of Cancer
|
October 17, 2003
A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
S Madhusudan, A Protheroe, D Propper, et al.
Nature Medicine
|
July 8, 1999
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis
R J Moore, D M Owens, G Stamp, et al.
Cell Proliferation
|
September 20, 2007
Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression
N F Li, S Broad, Y J Lu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust
F Balkwill, R C Bast, J Berek, et al.
Cancer Research
|
August 27, 1999
The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients
P Thavasu, D Propper, A McDonald, et al.
Oncogene
|
January 24, 2012
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
K M Archibald, H Kulbe, J Kwong, et al.
British Journal of Cancer
|
May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
P H Jones, K Christodoulos, N Dobbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C
D J Propper, A C McDonald, A Man, et al.
British Journal of Cancer
|
May 27, 2010
Guidelines for the welfare and use of animals in cancer research
P Workman, E O Aboagye, F Balkwill, et al.
Page
of 4